BlackRock Health Sciences Trust (NYSE:BME) Short Interest Up 189.8% in September

BlackRock Health Sciences Trust (NYSE:BME) was the target of a large increase in short interest in the month of September. As of September 30th, there was short interest totalling 14,200 shares, an increase of 189.8% from the September 15th total of 4,900 shares. Based on an average daily volume of 25,900 shares, the days-to-cover ratio is presently 0.5 days.

NYSE BME opened at $46.15 on Thursday. The company has a fifty day simple moving average of $48.22 and a 200 day simple moving average of $48.12. BlackRock Health Sciences Trust has a 12-month low of $41.00 and a 12-month high of $50.94.

The firm also recently declared a monthly dividend, which will be paid on Friday, October 29th. Investors of record on Friday, October 15th will be given a $0.213 dividend. The ex-dividend date is Thursday, October 14th. This represents a $2.56 annualized dividend and a yield of 5.54%. This is an increase from BlackRock Health Sciences Trust’s previous monthly dividend of $0.20.

Institutional investors and hedge funds have recently bought and sold shares of the business. Northwestern Mutual Wealth Management Co. boosted its holdings in BlackRock Health Sciences Trust by 29.9% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,806 shares of the company’s stock worth $87,000 after acquiring an additional 416 shares during the last quarter. Rockefeller Capital Management L.P. raised its holdings in BlackRock Health Sciences Trust by 9.3% in the second quarter. Rockefeller Capital Management L.P. now owns 3,562 shares of the company’s stock worth $172,000 after purchasing an additional 302 shares in the last quarter. Lincoln National Corp bought a new position in BlackRock Health Sciences Trust in the second quarter worth $204,000. Oppenheimer & Co. Inc. bought a new position in BlackRock Health Sciences Trust in the second quarter worth $227,000. Finally, HBK Sorce Advisory LLC purchased a new stake in shares of BlackRock Health Sciences Trust during the second quarter valued at $279,000.

About BlackRock Health Sciences Trust

BlackRock Health Sciences Trust is a closed-end investment fund. Its investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. The company was founded on March 31, 2005 and is headquartered in Wilmington, DE.

Featured Article: Dead Cat Bounce

Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.